{"disease":{"id":"anal-high-grade-squamous-intraepithelial-lesion","name":"anal high grade squamous intraepithelial lesion"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02135419","title":"Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4446,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT05531799","title":"Anal HSIL Screening Algorithm","phase":"NA","overall_status":"COMPLETED","enrollment_count":950,"lead_sponsor_name":"Institute of HIV Research and Innovation Foundation, Thailand","has_results":false},{"nct_id":"NCT02836522","title":"Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)","phase":"","overall_status":"COMPLETED","enrollment_count":406,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06651957","title":"Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)","phase":"","overall_status":"COMPLETED","enrollment_count":217,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03051516","title":"HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":188,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT04563754","title":"The Effectiveness of High Resolution Microendoscopy for People Living With HIV","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"Baylor College of Medicine","has_results":true},{"nct_id":"NCT02059499","title":"Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT06206564","title":"Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Frantz Viral Therapeutics, LLC","has_results":false},{"nct_id":"NCT05858021","title":"COrSIcA: Disease Measurement","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"David Finch","has_results":false},{"nct_id":"NCT05555862","title":"Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":17,"lead_sponsor_name":"Frantz Viral Therapeutics, LLC","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}